(Memphis, Tenn – January 12th, 2024) The protein HOXA9 is overexpressed in most acute myeloid leukemia (AML) cases and is associated with poor patient outcomes. However, HOXA9 is a difficult protein ...
"We’re the first to demonstrate that HOXA9 acts as a switch rather than a spectrum and separates patients into 2 distinct cohorts, where the high-expressing cohort has a worse prognosis." — Benjamin A ...
(L to R) Co-author Judith Hyle, first author Shaela Fields, corresponding author Chunliang Li, Ph.D., co-authors Shelby Mryncza and Zhenling Liu, all of the Li Lab, St. Jude Department of Tumor Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback